Analyst Ratings for Bristol-Myers Squibb Co. (BMY)

Updated: 2017-07-28

Bristol-Myers Squibb Co. (NYSE:BMY) was awarded an average rating of Overweight from investment analysts following the stock. Last month, BMY received an average rating of Overweight.

24 analysts issued ratings on the stock, where 10 gave BMY a buy rating, 1 gave an overweight rating, 10 issued a hold rating, 1 issued an underweight rating, and 2 gave a sell rating. Compared to three months ago, there has been an decrease of 1 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 1.

Many analysts weighed in on price targets for BMY. The highest price target was 68, implying potential capital gains of 25.37 percent. The most pessimistic price target was 40, which equates to a potential downside of -26.25 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0.68 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 4.27 percent. Meanwhile, fiscal year estimates have been revised upwards by 0.34 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 3.53 percent.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 3 analysts increased their quarterly estimates, while 4 analysts revised their estimates downwards. Over the same time period, 4 analysts revised their FY earnings estimates upwards, compared to 3 analysts that revised their FY estimates downwards.

Analysts estimate earnings of BMY to grow at a rate of 3.52 percent. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. People often look for the PEG ratio to be under 1, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of BMY is 5.6.

In the last 52-weeks, BMY has achieved a high of 76.48 and a low of 46.01. The current market price is above the trailing year's low by 17.89 percent, and 29.08 percent below the high. BMY has a price/earnings ratio of 19.72. Investors typically compare the P/E ratio to a company's peers in the industry. The BMY value stock report compares BMY to some of its peers using value stock charts. The stock has a market capitalization of $92.22 billion. BMY's next earnings release will be on 0000-00-00, which is days away.